| Hint | Answer | % Correct |
|---|---|---|
| phospholipase 4 | C | 88%
|
| phospholipase 5 | D | 50%
|
| Chylomicrons, HDL, VLDL, IDL | E | 50%
|
| Polar head 4 | glycerol | 38%
|
| Membrane lipid 1 | phosphatidyl choline | 38%
|
| Membrane lipid 4 | sphingomyelin | 38%
|
| phospholipase 1 | A1 | 25%
|
| phospholipase 2 | A2 | 25%
|
| phospholipase 3 | B | 25%
|
| second messenger 5 | Ca | 25%
|
| 18:2 | linoleic acid | 25%
|
| 16:0 | palmitic acid | 25%
|
| Membrane lipid 3 | phosphatidyl ethanolamine | 25%
|
| Membrane lipid 2 | phosphatidyl serine | 25%
|
| Polar head 3 | serine | 25%
|
| Chylomicrons | A4 | 13%
|
| aom | active oxygen method | 13%
|
| 18:3 | a-linolenic acid | 13%
|
| 20:0 | arachidic acid | 13%
|
| 20:4 | arachidonic acid | 13%
|
| Chylomicrons and VLDL | B48 | 13%
|
| 22:0 | behenic acid | 13%
|
| antioxidant 1 | BHA | 13%
|
| antioxidant 2 | BHT | 13%
|
| Chylomicrons, HDL, VLDL, IDL | C2 | 13%
|
| second messenger 1 | cAMP | 13%
|
| ceramides with a single sugar residue head | cerebrosides | 13%
|
| second messenger 2 | cGMP | 13%
|
| Polar head 1 | choline | 13%
|
| intracellular a2 type 1 | cPLA2 | 13%
|
| alternative bile pathway | CYP27A1 | 13%
|
| Classic bile pathway | CYP7A1 | 13%
|
| radical source 2 | cytoplasm | 13%
|
| second messenger 3 | DAG | 13%
|
| 22:6 | DHA | 13%
|
| 20:5 | EPA | 13%
|
| Polar head 2 | ethanolamine | 13%
|
| Stage 1 cholesterol | form HMG CoA | 13%
|
| Stage 2 cholesterol | form isoprenoids | 13%
|
| ceramides with oligosaccharide head 1 sialic acid | gangliosides | 13%
|
| lipid oxidation byproduct 1 | HPNE | 13%
|
| HNE | hydroxynonenal | 13%
|
| steps of lipid oxidation 1 | initiation | 13%
|
| second messenger 4 | IP3 | 13%
|
| intracellular a2 type 2 | iPLA2 | 13%
|
| 12:0 | lauric acid | 13%
|
| 24:0 | lignoceric acid | 13%
|
| secreted a2 type 1 | Lp-PLA2 | 13%
|
| radical source 3 | lysosomes | 13%
|
| MDA | malondialdehyde | 13%
|
| radical source 1 | mitochondria | 13%
|
| location of acyl CoA synthetase | mitochondrial membrane | 13%
|
| Polar head 5 | myo-inositol | 13%
|
| 14:0 | myristic acid | 13%
|
| 24:1 | Nervonic acid | 13%
|
| osi | oil stability index | 13%
|
| 18:1 | oleic acid | 13%
|
| lipid oxidation byproduct 2 | ONE | 13%
|
| ORAC | oxygen radical absorbance capacity | 13%
|
| ONE | oxynonenal | 13%
|
| 16:1 | palmitoleic acid | 13%
|
| radical source 4 | peroxisomes | 13%
|
| second messenger 6 | phosphoinositides | 13%
|
| steps of lipid oxidation 2 | propagation | 13%
|
| antioxidant 4 | Propyl gallate | 13%
|
| secreted a2 type 2 | sPLA2 | 13%
|
| Stage 4 cholesterol | squalene and oxygen form cholesterol | 13%
|
| Stage 3 cholesterol | squalene from 6 isoprenoids | 13%
|
| 18:0 | stearic acid | 13%
|
| antioxidant 3 | TBHQ | 13%
|
| steps of lipid oxidation 3 | termination | 13%
|
| TRAP | total radical trapping antioxidant parameter | 13%
|
| IDL, VLDL, LDL | B100 | 0%
|
| lipid oxidation byproduct 3 | HNE | 0%
|